Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by juniper88on Apr 18, 2019 9:03pm

112 Views

Post# 29647748

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:General response

My lowest buy was 23 cents. But I bought and sold those warrants for a huge profit. I have put $35k total in my TFSA, taken out $95000 and still have 95k shares in Athe TFSA. Is my CBA negative now? (I also own 130k shares in my RRSP)

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions